Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
Operating Expenses | 10,428 | 16,578 | 16,138 | 18,008 | 9,394 |
Operating Income | -10,428 | -16,578 | -16,138 | -18,008 | -9,394 |
Interest Expense | 484 | 471 | 479 | 478 | 499 |
Other Income | 982 | 1,240 | 1,504 | 1,638 | 1,810 |
Pre-tax Income | -9,930 | -15,809 | -15,113 | -16,848 | -8,082 |
Net Income Continuous | -9,930 | -15,809 | -15,113 | -16,848 | -8,082 |
Net Income | $-9,930 | $-15,809 | $-15,113 | $-16,848 | $-8,082 |
EPS Basic Total Ops | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 |
EPS Basic Continuous Ops | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 |
EPS Diluted Total Ops | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 |
EPS Diluted Continuous Ops | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 |
EPS Diluted Before Non-Recurring Items | -0.17 | -0.27 | -0.25 | -0.28 | -0.14 |
EBITDA(a) | $-10,776 | $-16,979 | $-16,583 | $-18,471 | $-9,505 |